ADAR1 Capital Management »

Cabaletta Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $152k 8.9k 17.06

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Cabaletta Bio

Jennison Associates
BlackRock
BlackRock
Fred Alger Management
T. Rowe Price Investment Management
Vanguard Group
State Street Corporation
Bain Capital Life Sciences Investors
VR Adviser
Sofinnova Ventures
Stempoint Capital
Commodore Capital
Geode Capital Management
Point72 Asset Management
Victory Capital Management

View all funds holding Cabaletta Bio